Non-specific and specific immunotherapy in patients with melanoma.
D000328:Adult; D000368:Aged; D000372:Agglutination Tests; D000917:Antibody Formation; D000941:Antigens; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007167:Immunotherapy; D037102:Lectins; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D008875:Middle Aged; D009163:Mycobacterium bovis; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*
D000941:Antigens; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D037102:Lectins